A lipid nanoparticle formulation degrades an immunosuppressive receptor on tumour-associated macrophages through its lipids alone, while its messenger RNA cargo reprograms these cells in situ into anti-tumour chimeric antigen receptor macrophages, reshaping the immune microenvironment of malignant ascites in gastrointestinal cancer.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
Learn more
Subscribe to this journal
Receive 12 print issues and online access
Learn more
Rent or buy this article
Prices vary by article type
Learn more
Prices may be subject to local taxes which are calculated during checkout
References
Li, Y. et al. Nat. Mater.
https://doi.org/10.1038/s41563-026-02769-2(2026).Banik, S. M. et al. Nature 584, 291–297 (2020).
Qi, C. et al. Nat. Med. 30, 2224–2234 (2024).
Liu, Y. et al. Nat. Nanotechnol. 20, 296–302 (2025).
Reiss, K. A. et al. Nat. Med. 31, 1171–1182 (2025).
Kang, M. et al. Adv. Mater. 33, 2103258 (2021).
Cheng, Q. et al. Nat. Nanotechnol. 15, 313–320 (2020).
Dilliard, S. A., Cheng, Q. & Siegwart, D. J. Proc. Natl...